General Information
Version
1.87
Revision date
2022-06-22
Product name
SIMPONI 1X100MG AUTOINJ. UKR
Substance name
SIMPONI
1.2.1 Relevant identified uses
Finished Pharmaceutical Product
supplier name
Janssen Pharmaceutica NV
Emergency telephone
+3214602111, 1-800-424-9300, +1 703-741-5970
Icons in SDS
Company Information
company name
Janssen Pharmaceutica NV
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJanssen@its.jnj.com
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Not a hazardous substance or mixture., Medicinal products in the finished state, intended for the final user, are not subject to GHS labeling.
Ingredient(s) with unknown acute toxicity
42 %
2.3 Other hazards
This Finished Pharmaceutical Product is non-hazardous based on chemical classification rules. Avoid direct contact and significant aerosol/dust exposure which has the remote possibilities of eliciting an allergic response. May cause sensitization in susceptible persons. This material is not likely to be significantly absorbed via occupational routes of entry due to its chemical structure and large molecular weight. Accidental injection may cause effects similar to those seen in clinical use and mentioned in the patient packaging insert. Refer to the pharmacotherapeutic group (section 1.2) and the patient packaging insert to evaluate the possible workplace hazards when this Finished Pharmaceutical Product is accidently leaking, broken or crushed.
2.1 Classification of the substance or mixture
1910.1200) Not a hazardous substance or mixture.
